Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 9 , Pages 654-659 , November 2009

Hyperhomocysteinaemia and poor vitamin B status in chronic obstructive pulmonary disease

  • F.L. Fimognari

      Affiliations

    • Unit of Respiratory Diseases, Division of Internal Medicine, Leopoldo Parodi Delfino Hospital, ASL Roma G, Colleferro (Rome), Italy
    • Corresponding Author InformationCorrespondence to: Filippo Luca Fimognari, Via Federigo Verdinois 30, 00159 Rome, Italy. Tel.: +39 064066824; fax: +39 0697223215.
    • ,
  • L. Loffredo

      Affiliations

    • Division of IV Medical Clinic, Department of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy
    • ,
  • S. Di Simone

      Affiliations

    • Unit of Respiratory Diseases, Division of Internal Medicine, Leopoldo Parodi Delfino Hospital, ASL Roma G, Colleferro (Rome), Italy
    • ,
  • F. Sampietro

      Affiliations

    • Coagulation Service and Thrombosis Research Unit, S. Raffaele Hospital, IRCCS, Milan, Italy
    • ,
  • R. Pastorelli

      Affiliations

    • Unit of Respiratory Diseases, Division of Internal Medicine, Leopoldo Parodi Delfino Hospital, ASL Roma G, Colleferro (Rome), Italy
    • ,
  • M. Monaldo

      Affiliations

    • Laboratory of Clinical Pathology, Leopoldo Parodi Delfino Hospital, ASL Roma G, Colleferro (Rome), Italy
    • ,
  • F. Violi

      Affiliations

    • Division of IV Medical Clinic, Department of Experimental Medicine and Pathology, University La Sapienza, Rome, Italy
    • ,
  • A. D'Angelo

      Affiliations

    • Coagulation Service and Thrombosis Research Unit, S. Raffaele Hospital, IRCCS, Milan, Italy

Received 12 August 2008 ,Revised 31 October 2008 ,Accepted 5 December 2008.

References 

  1. Engström G, Wollmer P, Hedblad B, Juul-Möller S, Valind S, Janzon L. Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function: a study from the “men born in 1914”, Malmö, Sweden. Circulation. 2001;103:3086–3091
  2. Sin DD, Wu L, Man SF. The relationship between lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952–1959
  3. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet. 1996;348:567–572
  4. Arboix A, Morcillo C, Garcia-Eroles L, Oliveres M, Massons J, Targa C. Different vascular risk factor profiles in ischemic stroke subtypes: a study from the “Sagrat Cor Hospital of Barcelona Stroke Registry”. Acta Neurol Scand. 2000;102:264–270
  5. Ambrosetti M, Ageno W, Spanevello A, Salerno M, Pedretti RF. Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD. Thromb Res. 2003;112:203–207
  6. Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of chronic inflammation in COPD. Circulation. 2003;107:1517–1519
  7. Fimognari FL, Scarlata S, Conte ME, Antonelli Incalzi R. Mechanisms of atherothrombosis in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3:89–96
  8. Sin DD, Man SF, Marciniuk DD, Ford G, FitzGerald M, Wong E, et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;177:1207–1214
  9. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1–11
  10. Homocysteine Studies Collaboration . Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288:2015–2022
  11. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006;354:1578–1588
  12. The Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators . Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med. 2006;354:1567–1577
  13. B-Vitamin Treatment Trialists' Collaboration . Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials. Am Heart J. 2006;151:282–287
  14. Seemungal TA, Cho Fook Lun J, Davis G, Neblett C, Chinyepi N, Dookhan C, et al. Plasma homocysteine is elevated in COPD patients and is related to COPD severity. Int J Chron Obstruct Pulmon Dis. 2007;2:313–321
  15. Kai S, Nomura A, Morishima Y, Ishii Y, Sakamoto T, Hegab AE, et al. The effect of smoking-related hyperhomocysteinemia on spirometric declines in chronic obstructive pulmonary disease in elderly Japanese. Arch Gerontol Geriatr. 2006;42:117–124
  16. Andersson A, Ankerst J, Lindgren A, Larsson K, Hultberg B. Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease. Clin Chem Lab Med. 2001;39:229–233
  17. Schols AM. Nutritional and metabolic modulation in chronic obstructive pulmonary disease management. Eur Respir J. 2003;22:81S–86S
  18. Global Strategy for Asthma Management and Prevention. NIH publication no. 02-3659, 2003 document (2004 update), Chapter 5. p. 67–71.
  19. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbation. Chest. 2000;117(5 Suppl. 2):398S–401S
  20. Fimognari FL, Scarlata S, Pastorelli R, Antonelli Incalzi R. Restrictive ventilatory dysfunction and dyspnea in elderly subjects. Am J Med. 2005;118:1300–1301
  21. Fermo I, Arcelloni C, Mazzola G, D'Angelo A, Paroni R. High-performance liquid chromatographic method for measuring total plasma homocysteine levels. J Chromatogr B Biomed Sci Appl. 1998;719:31–36
  22. Camp VM, Chipponi J, Faraj BA. Radioenzymatic assay for direct measurement of plasma pyridoxal-5′-phosphate. Clin Chem. 1983;29:642–644
  23. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  24. Classification Committee of WONCA . International classification of health problems in primary care (ICHPPC)-2-defined. 3rd ed.. Oxford: Oxford University Press; 1983;
  25. Rutten FH, Cramer MJ, Lammers JW, Grobbee DE, Hoes AW. Heart failure and chronic obstructive pulmonary disease: an ignored combination?. Eur J Heart Fail. 2006;8:706–711
  26. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007;369:1876–1882
  27. Clarke R, Refsum H, Birks J, Grimley Evans J, Johnston C, Sherliker P, et al. Screening for vitamin B12 and folate deficiency in older persons. Am J Clin Nutr. 2003;77:1241–1247
  28. Mennen LI, Potier de Courcy G, Guilland JC, Ducross V, Bertrais S, Nicolas JP, et al. Homocysteine, cardiovascular disease risk factors, and habitual diet in the French Supplementation with Antioxidant Vitamins and Minerals Study. Am J Clin Nutr. 2002;76:1279–1289
  29. Oron-Herman M, Rosenthal T, Sela BA. Hyperhomocysteinemia as a component of syndrome X. Metabolism. 2003;52:1491–1495
  30. Folsom AR, Desvarieux M, Nieto FJ, Boland LL, Ballantyne CM, Chambless LE. B vitamin status and inflammatory markers. Atherosclerosis. 2003;169:169–174
  31. Chiang EP, Smith DE, Selhub J, Dallal G, Wang YC, Roubenoff R. Inflammation causes tissue-specific depletion of vitamin B6. Arthritis Res Ther. 2005;7:R1254–R1262

PII: S0939-4753(08)00254-8

doi: 10.1016/j.numecd.2008.12.006

Nutrition, Metabolism & Cardiovascular Diseases
Volume 19, Issue 9 , Pages 654-659 , November 2009

Article Tools